Cytek Biosciences (NASDAQ:CTKB – Get Free Report) will likely be releasing its Q2 2026 results after the market closes on Wednesday, August 5th. Cytek Biosciences (NASDAQ:CTKB – Get Free Report) last released its earnings results on Thursday, May 7th. Get Cytek Biosciences alerts:Cytek Biosciences Trading Up 2.1%Shares of CTKB opened at $4.31 on Tuesday. Cytek Biosciences Company Profile(Get Free Report)Cytek Biosciences is a biotechnology company specializing in innovative cell analysis solutions. Read MoreReceive News & Ratings for Cytek Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytek Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.